SCHEMBL2720358

SCHEMBL2720358

CN1CCC(NC(c2ccccc2)c2nc3ccccc3[nH]2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 3/20 0.45
▸ KMT2A Q03164 1/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ ALPL P05186 1/20 0.41
▸ HTR3A P46098 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ DRD1 P21728 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ OPRM1 P35372 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722513 0.92 MLKL (0.51) HRH4KMT2AMAPK1HTR3ALMNA
SCHEMBL2723739 0.90 VCP (0.40) HRH4KMT2AMAPK1ALPLHTR3A
SCHEMBL900372 0.89 ALPL (0.41) HRH4KMT2AALPLHTR3ALMNA
SCHEMBL2722467 0.89 MLKL (0.43) HRH4KMT2AMAPK1ALPLHTR3A
SCHEMBL20503150 0.89 HRH4 (0.41) HRH4KMT2AHTR3ALMNAIDO1
SCHEMBL2722838 0.88 HRH4 (0.40) HRH4KMT2AMAPK1ALPLHTR3A
SCHEMBL2720674 0.88 HRH4 (0.40) HRH4HTR3ALMNAALDH1A1POLB
SCHEMBL2722093 0.88 KMT2A (0.41) HRH4KMT2AHTR3ALMNAIDO1
SCHEMBL899828 0.88 HRH4 (0.42) HRH4KMT2AHTR3ALMNAIDO1
SCHEMBL900156 0.88 PDE10A (0.39) HRH4KMT2AMAPK1ALPLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 — — EP claimed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 — — WO claimed
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 — — EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 — — US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 — — US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 — — EP disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 — — WO disclosed
Send feedback